WebApr 3, 2024 · Cell Therapeutics Inc. CTIC said its drug Opaxio has been granted orphan-drug designation by the U.S Food and Drug Administration for the treatment of a malignant brain cancer. Web2 days ago · The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential. Weaknesses Low profitability weakens the company. The valuation of the company is particularly high given the cash flows generated by its activity.
CTI BioPharma to Participate in Two Upcoming Investor …
WebApr 3, 2024 · CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood ... WebAnalyst Ratings for Cti Biopharm Corp (CTIC) provide recommendations made by outside industry experts. Analyst Ratings for Cti Biopharm Corp (CTIC) provide recommendations made by outside industry experts. ... Performance Leaders. Percent Change Price Change Range Change Gap Up & Gap Down Five Day Gainers. Before & After Markets. Pre … grainger baptistry heater
All News for CTIC : CTI BioPharma - Zacks.com
WebMar 23, 2024 · The stock current value is $4.31.Recently in News on March At the end of the latest market close, CTI BioPharma Corp. (CTIC) was valued at $4.30. In that particular session, Stock kicked-off at the price of $4.45 while reaching the peak value of $4.49 and lowest value recorded on the day was $4.28. WebApr 10, 2024 · Cti Biopharma stock last closed at $4.23, up 3.68% from the previous day, and has decreased 11.88% in one year. It has overperformed other stocks in the Biotechnology industry by 0.15 percentage points. Cti Biopharma stock is currently … WebApr 6, 2024 · 6 brokers have issued 12 month price targets for CTI BioPharma's shares. Their CTIC share price forecasts range from $9.00 to $13.00. On average, they expect the company's share price to reach $10.67 in the next year. This suggests a possible upside … china mars spacecraft